AARD vs AMD · $284.4M cap vs P/E 157, rev $11.54B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Advanced Micro Devices Inc (AMD) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Advanced Micro Devices Inc (AMD) is a semiconductors company listed on US. It is led by Lisa Su.
AARD does not have a complete income-statement cache yet.
Latest reported AMD revenue for 2026-06-27 was $11.54B. Net income was $2.30B. Revenue was up 12.5% from 2026-03-28 to 2026-06-27. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
AARD currently screens at market cap $284.4M. AMD currently screens at market cap $760.48B and trailing P/E 156.5.
Not investment advice. Open the AARD and AMD stock pages for the full models.
Not investment advice.